Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 α in alcoholic liver disease

Gut

Volumn 45, Issue 3, 1999, Pages 416-420

  Fisher, N C ^a   Neil, D A H ^a   Williams, A ^a   Adams, D H ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Alcoholic liver disease; Chemokines; Macrophage inflammatory protein 1 ; Monocyte chemoattractant protein 1

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALCOHOL LIVER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; GLYCOCALYX; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION;

EID: 0032795476     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.3.416     Document Type: Article

References (28)

1. 1 Anonymous. Alcoholic liver disease: morphological manifestations. Lancet 1981;i:707-11.
2. 2 Paronetto F. Immunological reactions in alcoholic liver disease. Semin Liver Dis 1993;13:183 95.
3. 3 Czaja MJ, Geerts A, Xu J, et al. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukocyte Biol 1994;55: 120 6.
4. 4 Adams DH, Afford SC, Fear J, et al. Hepatic expression of macrophage inflammatory protein-1 β after liver transplantation. Transplantation 1996;61:817-25.
5. 5 Maltby J, Wright S, Bird G, et al. Chemokine levels in human liver homogenates: association between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996;24:1156-60.
6. 6 Afford SC, Fisher NC, Neil D, et al. Distinct patterns of chemokine expression are associated with leucocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998;186:82-9.
7. 7 Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis - correlation with monocyte infiltration. Am J Pathol 1998;152:423-30.
8. 8 Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392;565 8.
9. 9 Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
10. 10 Tanaka Y, Kimata K, Adams DH, et al. Modulation of cytokine function by heparan sulfate proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc Ass Am Phys 1998;110:118-25.
11. 11 Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993;18:576-80.
12. 12 Masumoto T, Onji M, Horiike N, et al. Assay of serum interleukin-8 levels in patients with alcoholic hepatitis. Alcohol Alcohol 1993;28:99 102.
13. 13 Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18: 41 6.
14. 14 Bossink AW, Paemen L, Jansen PM, et al. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995;86:3841-7.
15. 15 Maddrey WC. Alcoholic hepatitis: pathogenesis and approaches to treatment. Scand J Gastroenterol 1990;175:118 30.
16. 16 Jiang Y, Beller DI, Frendl G, et al. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-8.
17. 17 Van Zee KJ, Fischer E, Hawes AS, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746-52.
18. 18 Luscinskas FW, Kiely JM. Ding H, et al. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992;149: 2163-71.
19. 19 R&D Quantikine (Human MCP-1 immunoassay) handbook. Catalogue no. DCP00. Oxon, UK: R&D Systems Europe.
20. 20 Abdullah MS, Wild G, Jacob V, et al. Cytokines and the malnutrition of chronic renal failure. Miner Energy Metab 1997;23:237-42.
21. 21 Akahoshi T, Kobayashi N, Hosaka S, et al. In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol Dial Transplant 1995;10: 2244-9.
22. 22 Khoruts A, Stahnke L, McClain CJ, et al. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13: 267-70.
23. 23 Bode C, Kugler V, Bode JC. Endotoxaemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8 14.
24. 24 McClain CH, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170 82.
25. 25 Armendariz-Borunda J, Seyer JM, Postlethwaite AE, et al. Kupffer cells from carbon tetrachloride-injured rat liver produce chemotactic factors for fibroblasts and monocytes: the role of tumour necrosis factor-alpha. Hepatology 1991; 14:895-900.
26. 26 Maher JJ. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of alcohol. Am J Physiol 1995;269:G518-23.
27. 27 Enomoto N, Ikejima K, Bradford B, et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroemerology 1998;115:443 51.
28. 28 Orrego H, Blake JE, Blendis LM, et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987;92:208 14.